Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). (original) (raw)
Find articles by Rigby, W. in:[JCI](/search/results?q=author.first%5Fname%3A%22W F%22+author.last%5Fname%3A%22Rigby%22&search%5Ftype=advanced) |PubMed |Google Scholar
Find articles by Stacy, T. in:JCI |PubMed |Google Scholar
Find articles by Fanger, M. in:[JCI](/search/results?q=author.first%5Fname%3A%22M W%22+author.last%5Fname%3A%22Fanger%22&search%5Ftype=advanced) |PubMed |Google Scholar
Published October 1, 1984 -Version history
Recent studies have suggested that vitamin D may have other important biologic activities in addition to its well-characterized role in the maintenance of calcium homeostasis. Discovery of cytosolic receptors for vitamin D in human peripheral blood monocytes and lectin-stimulated lymphocytes prompted us to study the effects of 1,25-dihydroxyvitamin D3 (calcitriol), the most biologically active metabolite of vitamin D, upon phytohemagglutinin (PHA)-induced lymphocyte blast transformation. We have found that calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Furthermore, calcitriol suppressed interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. Lastly, the suppressive effect of calcitriol on cellular proliferation was partially reversed by the addition of saturating amounts of purified IL-2. We conclude that calcitriol is a potent inhibitor of PHA-induced lymphocyte blast transformation and that this effect is mediated, in part, through suppression of IL-2 production. Thus, calcitriol appears to possess immunoregulatory properties that have been unappreciated heretofore.
Click on an image below to see the page. View PDF of the complete article